Bio-Medical Applications Of Pennsylvania, Inc. in Philadelphia, Pennsylvania - Dialysis Center

Bio-Medical Applications Of Pennsylvania, Inc. is a medicare approved dialysis facility center in Philadelphia, Pennsylvania and it has 13 dialysis stations. It is located in Philadelphia county at 301 West Chelten Avenue, Philadelphia, PA, 19144. You can reach out to the office of Bio-Medical Applications Of Pennsylvania, Inc. at (215) 844-1976. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Pennsylvania, Inc. has the following ownership type - Profit. It was first certified by medicare in May, 2016. The medicare id for this facility is 392846 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Pennsylvania, Inc.
Location	301 West Chelten Avenue, Philadelphia, Pennsylvania
No. of Dialysis Stations	13
Medicare ID	392846
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Pennsylvania, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1609249986
Organization Name	Fresenius Medical Care Of East Falls
Doing Business As	Bio-medical Applications Of Pennsylvania, Inc.
Address	301 W Chelten Ave Philadelphia, Pennsylvania, 19144
Phone Number	(215) 844-1976

Dialysis patients with Hemoglobin data

10

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	25
  Adult patient months included in Kt/V greater than or equal to 1.2	192
  Percentage of adult patients getting regular hemodialysis at the center	99
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Pennsylvania, Inc. with elevated calcium levels.

Patients with hypercalcemia	26
Hypercalcemia patient months	201
Patients with Serumphosphor	27
Patients with Serumphosphor less than 3.5 mg/dL	14
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	24
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	26
Patients with Serumphosphor from 5.6 to 7 mg/dL	27
Patients with Serumphosphor greater than 7 mg/dL	9

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	16
Patient months included in arterial venous fistula and catheter summaries	131
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	55
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	8

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	9
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Pennsylvania, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) Year	January, 2016 - December, 2016
Readmission Rate in facility	26.4 (As Expected)
Readmission Rate: Upper Confidence Limit	55.2
Readmission Rate: Lower Confidence Limit	9.2